Switch to
More onapp

How to use scorecard? Learn more

Lyka Labs Ltd

LYKALABS
Health CarePharmaceuticals
SmallcapWith a market cap of ₹550 cr, stock is ranked 1,822
High RiskStock is 3.50x as volatile as Nifty
158.153.94 (+2.55%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹550 cr, stock is ranked 1,822
High RiskStock is 3.50x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
175.84
PB RatioPB Ratio
7.94
Dividend YieldDiv. Yield
Sector PESector PE
51.72
Sector PBSector PB
6.72
Sector Div YldSctr Div Yld
0.52%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Lyka Labs Limited is a pharmaceutical products and services provider. The Company is primarily engaged in formulation and manufacturing lyophilized products.

Financial TrendFinancial statements 

202120222023202487.81196.1796.72112.64-11.5539.00-13.21-2.50
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 3.29%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Trading Window-XBRL 
Announced OnDec 19, 2024

LYKA LABS LIMITED has informed the Exchange about Closure of Trading Window | Download

LYKA LABS LIMITED has informed the Exchange about Closure of Trading Window | Download

Trading Window 
Announced OnDec 19, 2024

Lyka Labs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download

Lyka Labs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download

Loss/Duplicate-Share Certificate-XBRL 
Announced OnDec 2, 2024

LYKA LABS LIMITED has informed the Exchange about Issue of duplicate share certificates/Letter of Confirmation | Download

LYKA LABS LIMITED has informed the Exchange about Issue of duplicate share certificates/Letter of Confirmation | Download

See all events